Adipose extracellular vesicle CFD in growth hormone–driven insulin-dependent hepatic steatosis
Year: 2026
Type: preprint
Abstract: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, but how adipose tissue dysfunction drives hepatic steatosis remains unclear. Hepatic growth hormone (GH) resistance causes marked lipid accumulation, yet the contribution of adipose GH signaling is unknown. Here we show that adipose tissue–derived complement factor D (CFD) mediates hepatic steatosis in mice with liver-specific GH receptor ( Ghr ) deficiency by comparing liver-specific Ghr knockout mice ( L-Ghr −/− ) with mice lacking Ghr in both liver and adipose tissue. Cfd knockout protects against diet-induced obesity-associated steatosis and reduces steatosis in L-Ghr −/− mice, identifying CFD as a circulating driver of hepatic steatosis. Mechanistically, Adipose GH signaling promotes PPARγ–STAT5B-dependent Cfd transcription, and CFD is packaged into extracellular vesicles that enhance β-cell insulin secretion, promoting hepatic lipogenesis. Inhibiting CFD or its vesicular delivery alleviates steatosis in mice, and circulating vesicle-associated CFD correlates with disease severity in patients with MASLD.
Source: Research Square
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7236808345
